Medication info
Itevina Tablets (Terbinafine Hydrochloride)

Itevina Tablets (Terbinafine Hydrochloride)

Prescription medicationTablet
Ingredient · strength
Terbinafine Hydrochloride›140.625mg / 1 tablet
Manufacturer / importer
Eden Pharma Co., Ltd.
Appearance
White round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201908270 · Approved 2019.12.05 · Insurance code 628901470

Summary

Main use
Treatment of onychomycosis, cutaneous fungal infections (such as tinea pedis and tinea corporis), and tinea capitis
Who uses it
Adults · Children
Adult dosage
Administer terbinafine 125 mg per dose twice daily or 250 mg per dose once daily. The duration of treatment according to the condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually administered for 6 weeks~3 months. The treatment period may be shortened to 3 months or less in cases of infection of the fingernails or relatively small toenails, or in younger patients. A 3-month treatment period is usually sufficient for toenail infections, although some patients may require 6 months or longer. The treatment period may be longer in patients with slow nail growth. Reduce the daily dose by 1/2 in patients with a creatinine clearance below 50 mL/min.
Children's dosage
Administer to children 2 years and older. Administration is not recommended in children under 2 years because there is no experience with use in this age group. Tinea capitis: 4 weeks 1) Body weight below 20 kg (under 5 years): Administer 62.5 mg per dose once daily. 2) Body weight 20~40 kg (5 years∼12 years): Administer 125 mg per dose once daily. 3) Body weight over 40 kg (over 12 years): Administer 250 mg per dose once daily.

Ingredients

Manufacturer
Eden Pharma Co., Ltd.

Efficacy & effects

Treatment of onychomycosis, cutaneous fungal infections (such as tinea pedis and tinea corporis), and tinea capitis

  • Dermatophytosis
  • tinea pedis
  • tinea corporis
  • tinea cruris
  • onychomycosis
  • tinea capitis
View approved original text

This medication is used to treat tinea pedis, tinea corporis, tinea cruris, and onychomycosis caused by dermatophytes in adults. It is also used for the treatment of tinea capitis in children. In short, it helps effectively improve various dermatophyte infections.

Dosage and Administration

Adult dosage

Administer terbinafine 125 mg per dose twice daily or 250 mg per dose once daily. The duration of treatment according to the condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital, plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris: 2~4 weeks 2) Onychomycosis Treatment is usually administered for 6 weeks~3 months. The treatment period may be shortened to 3 months or less in cases of infection of the fingernails or relatively small toenails, or in younger patients. A 3-month treatment period is usually sufficient for toenail infections, although some patients may require 6 months or longer. The treatment period may be longer in patients with slow nail growth. Reduce the daily dose by 1/2 in patients with a creatinine clearance below 50 mL/min.

Children's dosage

Administer to children 2 years and older. Administration is not recommended in children under 2 years because there is no experience with use in this age group. Tinea capitis: 4 weeks 1) Body weight below 20 kg (under 5 years): Administer 62.5 mg per dose once daily. 2) Body weight 20~40 kg (5 years∼12 years): Administer 125 mg per dose once daily. 3) Body weight over 40 kg (over 12 years): Administer 250 mg per dose once daily.

Precautions

This medication is not recommended for patients with chronic or active liver disease. You must check for liver disease before taking this medication and undergo regular liver function tests (AST/ALT) before and during treatment. If symptoms suggestive of liver dysfunction (persistent nausea, loss of appetite, fatigue, vomiting, upper right abdominal pain, jaundice, etc.) occur, inform your doctor immediately and discontinue the medication. Hepatic failure can occur very rarely, so if liver damage progresses, discontinue use and conduct liver function tests. This medication should not be administered to patients with allergies to its components, blood disorders, severe renal failure, infants under 2 years of age, nursing mothers, or patients with certain hereditary lactose metabolism disorders. Caution should be exercised when administering to patients with renal impairment, the elderly, children under 20 kg, and patients with psoriasis or systemic lupus erythematosus. If serious skin reactions occur during treatment, discontinue use and seek medical attention immediately. This medication can cause various adverse reactions, including effects on the liver, blood, skin, musculoskeletal system, digestive system, and nervous system, so consult a doctor if any symptoms occur. This medication should only be used for fungal infections that cannot be treated topically, and if symptoms such as dizziness occur, driving or operating machinery should be avoided. There may be interactions with other medications, especially those affecting liver metabolism, so dosing adjustments and careful monitoring are necessary. Pregnant women or women who may become pregnant should use it with careful consideration of the treatment benefits and risks, and if nursing, breastfeeding should be discontinued. Children and the elderly may require special caution as drug concentrations may increase due to impaired liver or kidney function. In case of overdose, symptoms such as headache, nausea, abdominal pain, or dizziness may appear and immediate medical attention should be sought.

Side effects

Continuous nausea, loss of appetite, fatigue, vomiting, right upper abdominal pain, jaundice, dark urine, loose stools, cholangitis, hepatitis, bile duct obstruction, jaundice, rash, skin itching, fever, nausea, vomiting, decreased appetite, lethargy, elevated liver enzymes, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, skin hemorrhage, leukopenia, anemia, rash, itching, photosensitivity reaction, skin and mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, bullous dermatitis, psoriasiform rash, psoriasis exacerbation, hair loss, musculoskeletal reactions, arthralgia, myalgia, weakness, elevated CPK, rhabdomyolysis, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangiectasia, abdominal distension, dyspepsia, mild abdominal pain, diarrhea, gastric discomfort, thirst, glossitis, depression, anxiety, headache, taste disorder, dizziness, drowsiness, sensory disturbances, decreased sensation, decreased attention, insomnia, elevated BUN, polyuria, visual disturbances, tinnitus, anaphylactic reactions, angioedema, systemic lupus erythematosus, elevated serum total cholesterol, increased triglycerides, lethargy, tongue discoloration, palpitations, edema, menstrual irregularity, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reactions, serum sickness-like reactions, blurred vision, visual impairment, hearing loss, auditory dysfunction, vasculitis, permanent anosmia, hyposmia, drug rash accompanied by eosinophilia and systemic symptoms, pancreatitis, rhabdomyolysis, influenza-like illness, increased serum creatine phosphokinase, headache, nausea, upper abdominal pain, dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture from entering. It is advisable to store it at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.